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ABSTRACT OF THE THESIS
MOLECULAR MECHANISM OF DREAM DIMERIZATION AND
INTERACTIONS WITH A NON-PHYSIOLOGICAL LIGAND Zn^2+
by
Maria D. Santiago
Florida International University, 2019
Miami, Florida
Professor Jaroslava Miksovska, Major Professor
Downstream Regulatory Element Antagonist Modulator (DREAM) belongs to the family
of neuronal calcium sensor proteins and it is involved in several processes in the brain.
Zinc has been shown to bind to recoverin, with submillimolar affinity. Based on the high
sequence homology between the NCS family, it is proposed that DREAM can also serve
as an intracellular target for Zn2+. Fluorescence and CD studies confirm that zinc binds to
DREAM with a of K d= 4 µM, triggering changes in the proteins’ tertiary structure.
The calcium association to DREAM leads to the formation of a Ca

2+

bound dimer, while

in the apo state, a monomer-tetramer equilibrium was observed. A chimeric version of
DREAM was prepared by mutating the residues involved in dimerization. DREAM-NCS1
properties were investigated using spectroscopic techniques. These results point towards
the role of hydrophobic interactions and salt bridges in stabilizing the dimer and
propagating allosteric signals.
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1.

INTRODUCTION

1.1 Ca2+ storage and functions.
Calcium is an intracellular messenger, which is involved in several processes such as
neurotransmitter release, muscle contraction, and gene expression modulation. All these
processes are regulated by the spatial and temporal location of Ca2+ (Lock, Smith, &
Parker, 2019) (Fig.ure 1.1). The intracellular Ca2+ concentration is around 10-8 M and it is
maintained by Ca2+-ATPase pumps and Na+/Ca2+ exchange, as well as sequestering in
organelles such as the endosome, the Golgi apparatus, and the endoplasmic reticulum
(Permyakov, E. A. & Kretsinger, 2011). Intracellularly, the concentration of Ca2+ ions is
regulated by ligand-gated Ca2+ channels. Calcium is released in the ER by inositol
triphosphate (IP3) receptor linked channels and ryanodine receptors. In IP3 signaling,
phospholipase c, activated through the GPCR pathway, cleaves phosphatidylinositol
bisphosphate into IP3, which binds to IP3 receptors resulting in the release of Ca2+ from
the ER. It is worth mentioning that IP3 signaling requires the co-stimulation of Ca2+
resulting in Ca2+ induced-Ca2+ release mechanism (Lock et al., 2019) . Secondly, ryanodine
receptors can also be activated by molecules such as caffeine and stimulate Ca2+ release
(Permyakov, E. A. & Kretsinger, 2011). In excitable cells such as neurons, the
concentration of Ca2+ is mainly regulated by voltage gated Ca2+ channels. When the
membrane potential of the neurons is between -60 to -70 mV, the voltage gated Ca2+
channels are closed and the cell is in a resting state. On the other hand, when specific
channels are activated Ca2+ enters the cell resulting in neuronal excitation (Ramirez,
Gonzalez, Fissore, & Carvacho, 2017).
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Fig. 1.1: Processes that control Ca2+ storage and release in the eukaryotic cell (Dong,
Saikumar, Weinberg, & Venkatachalam, 2006)

1.2 Calcium binding proteins
Calcium binding proteins (CBP) are traditionally divided into two groups, Ca2+ buffers and
Ca2+ sensors (Permyakov & Kretsinger, 2011). Calcium buffer proteins such as
parvalbumin and calbildin are able to regulate intracellular Ca2+ concentration by binding
to the metal and participating in signal transduction (Permyakov & Kretsinger, 2011) . On
the other hand, Ca2+ sensors undergo conformational changes upon Ca2+ binding, which
ultimately modulate their affinity for intracellular partners. (Permyakov & Kretsinger,
2011)
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1.2 Calmodulin as a model protein for EF-hands calcium sensors
The study of calmodulin has provided a model for the members of the EF-hands calcium
sensors. Calmodulin is present in all eukaryotic cells (Permyakov & Kretsinger, 2011) and
it has been conserved during evolution because of its interactions with several partners in
Ca2+ signal transduction pathways (Permyakov & Kretsinger, 2011). The protein possesses
4 EF-hands and it is involved in several signal transduction pathways (Chazin, 2011;
Permyakov & Kretsinger, 2011). Calmodulin transduces the calcium signal by binding to
Ca2+, which triggers a conformational change resulting in a less compact structure than the
one in the apo form with exposed hydrophobic patches on the protein surface as shown in
Fig. 1.2 , allowing Ca2+ bound calmodulin to bind to the final target of the signaling
pathway (Permyakov, E. A. & Kretsinger, 2011).

Fig. 1.2: Structure of Apo Calmodulin (PDB entry 1CFD) . Structure of Ca2+Calmodulin (PDB entry 1CLL)
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The most significant Ca2+ induced change in calmodulin is the change in the orientation of
the helixes for each EF hand (Permyakov, E. A. & Kretsinger, 2011). In the apo form, the
first and last helixes are parallel to the central helix linker shown in Fig. 1.2, forming a
compact hydrophobic core (Permyakov, E. A. & Kretsinger, 2011). In the Ca2+ bound
calmodulin, these helixes move away from the central helix linker, resulting in a change in
the orientation with respect to the central helix linker, from 121-144 ° in the apo form to
86-116° in the Ca2+ bound calmodulin (Permyakov & Kretsinger, 2011). This observed
reorientation upon Ca2+ binding produces a solvent exposure of methionine residues and
concomitant formation of two hydrophobic concave patches that serve as binding sites for
the intracellular partners (Permyakov & Kretsinger, 2011).
1.3 Calcium coordination and binding site in EF –hand proteins
The calcium-binding site in EF-hand proteins is formed by a helix-loop-helix structure
where Ca2+ is coordinated to the protein in a pentagonal bipyramidal geometry as shown
in Fig. 1.3 (Gifford, Walsh, & Vogel, 2007). The helix-loop-helix is formed by an -helix,
a Ca2+ binding loop composed of nine residues, and an additional -helix composed of
eleven residues.(Gifford et al., 2007). The nine residues in the Ca2+ binding loop provide
five ligands for Ca2+ coordination and two extra ligands are provided by the side chain of
a Glu residue, resulting in the seven ligands that coordinate Ca2+ in the EF-loop (Gifford
et al., 2007). In addition, a water molecule forming hydrogen bonds with one of the side
chains of the loop completes the coordination sphere of Ca2+(Gifford et al., 2007). These
EF-loops are mostly composed of negatively charged amino acids Asp and Glu (Gifford et
al., 2007), reflecting the preference of the EF-loop for less bulky carboxy side chains as
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shown in Table 1.1 (Gifford et al., 2007). The coordination of Ca2+ bound to EF-hand 3
and EF-hand 4 is shown in Fig. 1.4.

Table 1.1: Sequence of amino acid residues in canonical calcium binding loop. Adapted
from (Gifford et al., 2007)
EF-loop
1
2
3
4
5
6
7
8
9
10
11
12
position
coordinati
X
Y
Z
-Y
-X
-Z
ng ligand
Most
Asp Lys Asp Gly Asp Gly Thr Ile Asp Phe Glu Glu
common
100 29
76
56
76
96
23
68
32
23
29
92
%
%
%
%
%
%
%
%
%
%
%
%
Also
frequently
observed

Ala Asn Lys Asn
Gln
Arg
Thr
Asn
Val
Ile
Ser
Glu
Arg
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Phe Val Ser Tyr Asp Asp
Lys Leu Thr Ala Lys
Gln
Glu Thr Ala
Tyr
Asn Leu Pro
Glu
Gly Glu Asn
Arg
Gln Lys

Fig. 1.3: Ca2+ coordination by the canonical EF-hand illustrating the pentagonal
bipyramidal coordination of the Ca2+ ion (continuous thin lines) and the hydrogen bonding
pattern in the loop (dashed lines) . The backbone NH groups are shown in black, the sidechain oxygen atoms in red, the Ca2+ ion in yellow and the coordinating water molecule in
blue (Gifford et al., 2007).

Fig. 1.4: Calcium coordination in EF-hand 3 (A) and EF-hand 4 (B) of neuronal calcium
sensor DREAM, (PDB entry 2JUL).

1.4 Ca2+ and neuronal calcium sensors in the brain
The concentration of Ca2+ ions plays a crucial role in neuronal activity (Burgoyne & Weiss,
2001), since it modulates several processes such as neurotransmitter release, short term
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rapid modulations of channel function, long-term switches in gene expression (Burgoyne
& Weiss, 2001), regulation of Kv4.3 and Kv1.5 potassium channels, and regulation of
presenilin processing (Pongs et al., 1993). The ability of Ca2+ to regulate such a variety of
processes is due to its interactions with numerous CPBs, which associate with other target
proteins involved in the process mentioned before. (Burgoyne, R. D. & Weiss, 2001)

1.5 Neuronal Calcium Sensors.

Neuronal calcium sensors (NCS) are expressed in retinal photoreceptors (Burgoyne &
Weiss, 2001) and in the brain (Burgoyne & Weiss, 2001; Permyakov & Kretsinger, 2011).
The family of proteins is in charge of regulating a variety of physiological processes
summarized in Fig. 1.5 and are linked to several pathological conditions such as Parkinson,
Huntington and Alzheimer’s disease (López-Hurtado et al., 2018). The family is composed
of five different classes: A,B,C,D, and E referring to frequenin, visinin-like protein
(VILIP), recoverins, guanylate cyclase (GC)-activating proteins (GCAPs), and Kvchannel-interacting proteins (KChIPs) (Burgoyne, R. D. & Weiss, 2001). The main
characteristics of the protein family are a tandem-like structural orientation of the N- and
C- terminal domain and posttranslational myristoylation of the N- terminal residue. In
addition, the sequence of the N- terminal domain shows a low sequence similarity, whereas
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the C- terminal domain sequence is homologous among the members of this family.
(Permyakov. & Kretsinger, 2011).

Fig. 1.5: Neuronal Calcium Sensor subfamilies classifications and main function Adapted
from (Permyakov, E. A. & Kretsinger, 2011)

Class A , frequenin (NCS-1), first appeared in yeast (Burgoyne & Weiss, 2001) and it can
bind up to three Ca2+ ions (Ames & Lim, 2012) and a myristoyl group can be found at the
N terminal allowing the protein to associate with lipid layers (Braunewell, Karl-Heinz &
Gundelfinger, 1999; Dason, Romero-Pozuelo, Atwood, & Ferrús, 2012) . Class B, VILIPs,
is formed by three members VILIP 1, 2 and 3. Visinin like proteins play a role in the
regulation of the desensitization of signal cascades in retinal photoreceptors in a Ca2+
depended manner (Braunewell, Spilker, Behnisch, & Gundelfinger, 1997). Class C is
formed by one protein, recoverin, which has one human gene (Burgoyne & Weiss, 2001).
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Recoverin is present in photoreceptor cells and its main function is to control light
sensitivity by regulating the phosphorylation of rhodopsin kinase (Calvert, Klenchin, &
Bownds, 1995). Furthermore, as in the case of NCS-1, recoverin interacts with a myristoil
group, which is responsible for inducing rhodopsin kinase inhibition in Ca2+ dependent
manner (Calvert et al., 1995). Class D is formed by GCAPs 1, 2 and 3 (Burgoyne & Weiss,
2001) and is expressed in the photoreceptors cells in the retina (Braunewell, Karl-Heinz &
Gundelfinger, 1999). The main function of GCAPs is to activate or inhibit guanylyl
cyclase in the retina (Burgoyne, Robert D. & Haynes, 2012). Class E is formed by KChIP
1, 2 and 3 (Burgoyne, R. D. & Weiss, 2001). They interact with the Kv4 family of A-type
potassium channels (Burgoyne & Haynes, 2012) and may participate in regulating voltagegated Ca2+ channel signaling (Burgoyne & Haynes, 2012) . The KChIP 1-4 family bind
with the cytosolic α-subunit of potassium channels, so called T1 domain (Ling et al., 2000),
forming a cross-shaped octamer (Findeisen, Hura, Minor, & Pioletti, 2006), Pioletti et al.
determined an X-ray structure of KChIP1 in complex with potassium channel showing that
each KChIP1 monomer interacts with two Kv4.3 T1 domains, forming an octamer which
is composed by four KChIP1s and four Kv4.3 subunits. (Findeisen et al., 2006), The first
KCHIP1- Kv4.3 binding site is formed by hydrophobic interactions among the
hydrophobic residues in the N terminal of Kv4.3 and a hydrophobic cavity on the surface
of KChIP1, so called Site 1 is composed of amino acids 2-22 from Kv4.3. The second
binding site is between the N terminal of KChIP1 and a T1 domain loop, so called Site 2,
and corresponds to amino acids 70-90 from the T1 domain (Findeisen et al., 2006). The
class E member KChIP 2 is present in cardiomyocytes and it has been proposed to interact
with presenilin and have a role in the ryanodine receptor-mediated Ca2+-induced
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Ca2+ release (Bähring, 2018). The third class E member, KChIP3 also known as DREAM
or calsenilin interacts with DNA and regulates gene expression of genes involved in pain
sensing such prodynorphin gene; it activates presenilin, and modulates kinetics of Kv
channels through interactions with the T1 domain. (Burgoyne, Robert D. & Haynes, 2012).
1.6 Downstream Regulatory Element Antagonist Modulator.
Downstream Regulatory Element Antagonist Modulator (DREAM) is a member of the
NCS family, which belongs to the potassium voltage channel subfamily (Carrión, Link,
Ledo, Mellström, & Naranjo, 1999). The DREAM protein is composed of 256 amino acids
and contains 4 EF hands as shown in Fig. 1.6. and 1.7. The EF hand 1 does not bind any
metal due to the presence of a proline residue within the metal binding loop, EF hand 2
binds to Mg2+ with an equilibrium dissociation constant of around 13 µM (Masanori Osawa
et al., 2005), and EF hand 3 and 4 bind to Ca2+ with an affinity of around 1 µM (Masanori
Osawa et al., 2005). DREAM also interacts with small hydrophobic molecules such as 1,8
ANS and arachidonic acid with an affinity modulated by Ca2+ binding to the protein.
(Gonzalez & Miksovska, 2014). The NMR structure of the truncated form (residue 76 to
256) of Ca2+ bound DREAM is shown in Fig. 1.6. Ten -helix were identified in the
truncated form with helices 2-5 forming EF-hand 1 and EF-hand 2 and helices 6-9 forming
EF-hand 3 and EF-hand 4. (Lusin, Vanarotti, Li, Valiveti, & Ames, 2008).
Previous studies have shown that DREAM is involved in several biological processes. Ooi
et al.(2008) have shown that DREAM is able to regulate learning and memory by inhibiting
the activity of cAMP Response Element Binding Protein (CREB). In the absence of Ca2+,
DREAM binds to DRE sequence, inhibiting the expression of genes regulated by
CREB/CREM complex. In the presence of Ca2+, DREAM dissociates from DNA allowing

10

the expression of CREB/CREM genes (Ooi & Wood, 2008) . Furthermore, in the absence
of Ca2+, DREAM interacts with CREB and CREM (cAMP Response Element Modulator)
inhibiting cAMP-mediated transcriptional activation (Ooi & Wood, 2008).

Fig. 1.6: DREAM structure determined by NMR. -helices are shown as ribbons with
the N-terminal domain shown in blue and the C-terminal domain in red, Ca2+ ions are
represented as green spheres. (PDB entry 2JUL)
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Fig. 1.7: Amino acid sequence of DREAM. The sequence corresponding to the individual
EF-hands is shown in green, red, blue and yellow.
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Furthermore, the binding of DREAM to DRE sequence is also involved in the
transcriptional repression of prodynorphin genes related to pain sensitivity and c-fos, cjunk, and hrk genes related to cell proliferation. This ability of DREAM to bind to DNA
makes it the only known CBP to regulate gene expression in a calcium dependent manner
(Carrión et al., 1999; Cheng & Penninger, 2004).
The DREAM protein like all members of KChIP proteins, modulates A-type potassium
currents by interacting with Kv4.3 potassium channels (Ling et al., 2000). Even though the
structure for KChIP1 in complex with potassium voltage channel is the only that has been
determined (Findeisen et al., 2006), the KChIP family has a high sequence similarity and
the amino acids involved in the stabilization of the KCHIP1-Kv4.3 interactions are
conserved throughout the KChIP family (Ling et al., 2000). Therefore, analogous
interactions are expected between all KChIPs and potassium voltage channels.
The importance of DREAM in neurological and neuropathological processes is clearly
demonstrated by the fact that DREAM is implicated in several neurological diseases such
as Alzheimer’s disease, Huntington and Parkinson disease (López-Hurtado et al., 2018).
Lilliehook et al. (1998) reported that DREAM interacts with the presenilin unit of the γsecretase complex and enhances the cleavage of amyloid precursor proteins into aβ42
plaques. The plaques are commonly found post-mortem as a diagnostic feature of patients
with Alzheimer’s disease (Lilliehook et al., 1998).
The precise mechanism of how Ca2+ modulates DREAM interaction with DNA and other
intracellular partner remains unknown. This protein has been shown to undergo an
oligomerization transition upon binding of Ca2+ (Masanori Osawa et al., 2005; Yu et al.,
2007). In the absence of Ca2+, DREAM presents a monomer-tetramer equilibrium whereas
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upon Ca2+ binding to the C- terminal domain, the protein forms a stable dimer (Carrión et
al., 1999; Gonzalez & Miksovska, 2014; Lusin et al., 2008). Previous studies have shown
that DREAM interacts with potassium channels as a monomer (Ping Liang et al., 2009; Yu
et al., 2007) in both the Ca2+ bound and Ca2+ free form, with presenilin and calmodulin as
a dimer, and with DNA as a monomer or tetramer (Carrión et al., 1999) suggesting that
changes in the protein oligomerization are important for Ca2+ signaling mechanism.

1.7 Objectives
Objective 1:
Zinc is a divalent cation, which possesses a filled d orbital, which means that it does not
participate in redox reaction. Because of this Zn2+ can be used as a cofactor in biological
reaction which do not required the presence of a metal, which can be involved in redox
reactions [JM1]
Previous studies have shown that Zn2+ is able to bind to Ca2+ buffer proteins such as
parvalbumin with a Kd of 5x10-5 M. (Permyakov, E. A. & Kretsinger, 2011) Furthermore,
Zn2+ is also able to bind to calmodulin albeit weakly with a dissociation constant od 10-3
M (Warren, Guo, & Tang, 2007). The metal binding site in proteins, which bind to Zn2+
usually, involve His Glu Asp and Cys. Some of the biological functions of Zn 2+ involve
neuronal growth and plasticity indicating a similar role as that of Ca2+. Recently[JM2]
published study by Permyakov et al. have shown that Zn2+ binds to a member of neuronal
calcium sensor family, recoverin with an affinity of 7.0 μM (Permyakov, S. E. et al., 2003).
Considering a high sequence and structural homology between members of NCS family, it
is proposed that DREAM can also serve as an intracellular target for Zn2+. With this in
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mind, we conducted fluorescence studies and circular dichroism studies to elucidate zinc
binding to DREAM and its impact on protein stability.

Objective 2:
Even though results from several research groups have addressed structural and functional
properties of DREAM, the molecular mechanism of calcium triggered signaling and
allosteric regulation with intracellular partners remains unknown for DREAM and other
members of the neuronal calcium sensor family. The goal of my thesis was to provide
insight into the Ca2+ triggered dimerization process of DREAM. Considering the high
sequence homology of the C- terminal domain among neuronal calcium sensors, the results
obtained in my study can be applied to other potassium channel interacting proteins and
other members of the neuronal calcium sensor family.
Previous studies by the Ames group suggested that hydrophobic interactions between Leu
residues (Leu155, Leu159 and Leu251) stabilize the dimeric form of the Ca2+ bound
DREAM dimer. However, the unpublished computational and polarization data from our
group indicate that two salt bridges between individual monomers (Arg 200, Arg 207, and
Glu 103) also contribute to the protein stability. To study the DREAM dimerization
mechanism, we designed a chimeric DREAM-NCS 1 protein. Taking into account that the
NCS1 protein does not form a dimer in the Ca2+ bound form, we have replaced residues in
the loop connecting EF-hand 3 and EF-hand 4 with the sequence found in NCS1. In
addition, hydrophobic residues Leu 157 and Leu 158 have been replaced by alanine residue
corresponding to the analogues residues in neuronal calcium sensor 1 (Thr 157 and Ser
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158) which does not form dimers. The alignment of the sequence of DREAM WT and
DREAM-NCS1 chimeric protein is shown in Figure 1.8. The structural properties of the
chimeric protein were investigated using steady state and time resolved fluorescence and
circular dichroism spectroscopy. In addition, interaction of the chimeric protein with the
peptides mimicking the DREAM binding sites in T1 domain of Kv channel were
characterized.
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2. MATERIALS AND METHODS
2.1 Chemicals and reagents

Reagents and solvents CaCl2, ZnCl2, MgCl2, EDTA and EGTA, as well as the reagents
required for the protein expression and purification were purchased from Sigma-Aldrich
or Fischer Scientific and were of analytical grade. The hydrophobic fluorescent probe 1,8ANS, was purchased from Invitrogen. 1,8-ANS, stock was prepared in ultrapure water
(18.2 MΩ) and stored at -20°C and the concentration was determined spectrophometrically
using the extinctions coefficients listed in Table 2.1.
Fluorescently labeled peptides Site 1 and Site 2 were purchased from Thinkpeptides, the
stocks were prepared in 20 mM Tris buffer pH 7.4 and the concentration was determined
spectrophotometrically using the extinction coefficients listed in Table 2.1.

2.2 Protein purification and isolation.
Recombinant mouse DREAM (65-256) protein with a His tag at the N-terminus was
expressed in E. coli (DE 21) (Invitrogen). Cells were grown in Terrific Broth (TB) media
at 37⁰C and 250 rpm speed for 12 h. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was
added when optical density at 600 nm (OD) reached 0.75 and cells were grown for
additional 12 h. Subsequently, cells were harvested by centrifugation at 4 °C and 5000 rpm
for 20 min (ST 16R centrifuge, Thermal Scientific) and treated with lysis buffer overnight.
The composition of the lysis buffer is 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM mercaptoethanol, 20% glycerol, 1mM phenylmethyl sulfonyl fluoride (PMSF), 0.2%
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Tween 20, 20 g/mL DNase I, 5 g/mL lysozyme, and 5 mM MgCl2 and pH 8.0 . Cells
were broken through sonication using a sonic dismembrator (model 100, Fisher Scientific)
for 40 intervals of 20 seconds with 2 min of resting on ice between each interval. Disrupted
cells were centrifuged for 4 hours at 5000 rpm and supernatant was collected. Supernatant
was then passed through a Ni-NTA affinity column (Quiagen) equilibrated with buffer A
containing 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM -mercaptoethanol, and 10%
glycerol. The column was washed with an increasing concentration of imidazole in buffer
A (10 mM , 20 mM and 40 mM) until the OD of the eluate at 280 was less than 0.02.
Finally, and the protein was eluted with buffer A containing 250 mM imidazole. Protein
was then dialyzed against a 20 mM Tris buffer pH 8.0 to remove residual imidazole and
passed through an anion exchanged di-ethyl-amino-ethyl (DEAE) column, which was
consecutively washed with 20 mM Tris buffer pH 8.0 containing an increasing NaCl
concentration (20 mM ,40 mM , and 80 mM NaCl). The protein was eluted with 200 mM
NaCl in 20 mM Tris buffer pH 8.0 and dialyzed against 20 mM TRIS pH 7.4 overnight.
The purity of the protein was determined using SDS-PAGE electrophoresis and the Ca2+
binding properties were characterized using emission spectroscopy and circular dichroism
spectroscopy as described below.

2.3 UV-VIS absorption

The presence of aromatic amino acid residues with conjugated electrons, Trp, Phe and Tyr,
peptides and proteins the ability to absorb light in the UV range from 250 nm to 300 nm.
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These conjugated systems allow to observe  ->* electronic transitions upon excitation
as shown in the Jablonski diagram (Figure 2.1)

Fig. 2.1: Representation of the Perrin-Jablonski diagram. The arrows indicate the transition
between the different electronic states. Radiative processes are shown , absorption is
represented by the blue arrow , emission is represented by the bright green arrow and
phosphorescence is represented by the orange arrow. The non-radiative processes, such as
internal conversion, intersystem crossing and vibrational relaxation are shown in red, flat
green and maroon respectively.
The absorbance (A) is determined as a ratio of the intensity of light before (Io) and after
(I) it passes through an optical cell according to (Eq 1).
𝐴 = log

𝐼𝑜

(1)

𝐼

based on the absorbance value, the concentration of the protein sample can be determined
using Beers Lambert Law (Eq. 2).
𝐴 = 𝜀𝑏𝑐

(2)
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where  is the extinction coefficient in cm-1M-1, b is the pathway in cm and c is the
concentration in mol L-1. The values of extinction coefficients used in this study are
summarized in Table 2.1.

Table 2.1: Extinction coefficient values used in this study
λ max (nm)
Extinction coefficient (cm1 -1
M )
DREAM WT
280
19 000
DREAM-NCS 1

280

19 000

1,8-ANS

350

5000

Kv 4.3 Site 1

493

80 000

Kv 4.3 Site 2

493

75 000

Source
(Azam &
Miksovska, 2019)
(Azam &
Miksovska, 2019)
(Stryer, 1965)
(Azam &
Miksovska, 2019)
(Azam &
Miksovska, 2019)

2.4 Steady state emission

The emission spectrum is the measure of the light intensity emitted by a sample as a
function of wavelength, after the sample has been excited at a specific wavelength
(Jameson, 2014; Lakowicz, 2006). The Trp residue is a commonly used intrinsic probe in
proteins as its emission properties can be used to monitor protein tertiary structure changes
due to its sensibility to the surrounding environment, (Jameson, 2014)
The DREAM protein has a unique Trp residue in position 169 located in a hydrophobic
cavity (Lusin et al., 2008) , which was used to monitored changes in the protein tertiary
structure upon Ca2+ association to the protein. The Trp emission spectra were recorded
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using PC1 fluorimeter. The samples were excited with a 280 nm output from the Xe lamp
and emission was collected in 90-degree orientation from 300 nm to 470 nm. The samples
for emission measurements contained 10-µM protein solubilized in 20 mM Tris buffer pH
7.4. The sample was placed in a 0.1x1.0 cm or 0.2 x 1.0 cm quartz cuvette. The apo, Mg2+,
Ca2+ and Mg2+Ca2+ bound protein was prepared by adding 5 mM EDTA,5 mM EGTA, 1
mM MgCl2 and/or 1 mM CaCl2 to the protein samples.
2.5 Fluorescence lifetime
Fluorescence lifetime of fluorophore (τ) is the measure of how much time the molecule
spends in the excited state, corresponding to the time between absorption and emission
(Jameson, 2014), and is commonly expressed using Eq. 3, where τ is the lifetime in ns ,
krad is the rate constant for radiative processes and knonrad is the rate constant for nonradiative processes.

𝜏=

1
𝑘𝑟𝑎𝑑+𝑘𝑛𝑜𝑛𝑟𝑎𝑑

(3)

The information of the lifetime of intrinsic or extrinsic fluorescence probes in protein
provide additional information and structural and dynamic properties in protein and are
important for interpreting other parameters such as lifetime and anisotropy (Jameson,
2014). Fluorescence lifetime can be measured using the time domain or the frequency
domain approach (Jameson, 2014). In the time domain approach the sample is excites with
a short laser pulse and the change in intensity is measured as a function of time (Jameson,
2014). On the other hand, in the frequency domain approach, the sample is excited using
a continuous light source modulated at different high frequencies (20 MHz to 200 MHz))
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in a sinusoidal manner, as a result of the excitation the sample, the emitted light shown a
frequency phase shift and amplitude modulation with respect to the excitation source
modulated emission light (Jameson, 2014; Lakowicz, 2006). The lifetime can be
determined by analyzing the experimental data using several models such as sum of
multiple exponential decay, Gaussian distribution, Lorents distribution etc. (Jameson,
2014) . The lifetime data presented in this study were measured in the frequency domain
using Chrono FM fluorometer (ISS, Chapagain Illinois)
The samples for Trp fluorescence lifetime measurements contained 20 μM protein in 20
mM Tris buffer pH 7.4. The apo, Mg2+, Ca2+ and Mg2+Ca2+ bound proteins were prepared
by adding 5 mM EDTA, 5 mM EGTA, 1 mM MgCl2 and/or 1 mM CaCl2 into proteins
samples. The compound 2.5-diphenyl-oxazole (PPO) with the lifetime of 1.4 ns was used
as a reference. The sample was excited with 280 nm laser diode and the emission intensity
was collected using a 300 nm long pass filter (Andover). The plots of phase modulation
and phase shift as a function of modulation frequency were fitted using a three exponential
decays model. The quality of the fit was judged by a 2 value and residual.
The samples for measuring emission lifetime of DREAM in the presence of 1,8-ANS
contained 20 μM protein in 20 mM Tris buffer pH 7.4 and 20 μM 1,8-ANS. The apo, Mg2+,
Ca2+ and Mg2+Ca2+ bound proteins were prepared by adding 5 mM EDTA, 5 mM EGTA,
1 mM MgCl2 and/or 1 mM CaCl2 into proteins samples. The samples were placed in a
0.1x1.0 cm or 0.2 x 1.0 cm quartz cuvette and the output of 305 nm diode was used for the
excitation. The emission intensity was collected using a 400 nm long pass filter (Andover
Corp). The plots of phase modulation and phase shift as a function of modulation frequency
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were fitted using a three exponential decays model. The quality of the fit was judged by a
2 value and residual.
2.6 Anisotropy
Anisotropy measurements allow to determine rotational mobility of a fluorophore by
monitoring the ratio of the emitted light using different orientation of polarizers placed in
the excitation and emission path according to Eq 4. (Jameson, 2014).
𝐴=

𝐼𝐼𝐼 −𝐼⊥

(4)

𝐼𝐼𝐼 +2𝐼⊥

where A represents anisotropy and III and I┴ represent the parallel and perpendicular
orientation of the polarizers. In general, the excitation light passes through a polarizer
placed in the excitation path and only fluorophore molecules that have a transition dipole

excitation

emission

Fig. 2.2: Position of the polarizers for the steady-state anisotropy measurements. The
Direction of the propagation of the excitation light and collected emitted light are shown as
thin black arrows, the orientation of the polarizer placed in the excitation and emission path
are shown in green. (Adapted from Jameson 2004).

22

moment aligned with the electric field of the excitation light are excited. The polarization
of the emitted light corresponds to the orientation of the transient dipole moment of the
excited molecule at the time of light emission (Lakowicz, 2006). For small molecules that
freely rotate in the solution, the emitted light is depolarized, whereas light emitted by
molecules or molecules trapped in a membrane or a solid like environment emit light
polarized in the orientation analogous to the polarization of the excitation light. (Jameson,
2014) A second polarizer placed in the path of the emitted light is in a parallel or
perpendicular orientation with respect to the polarizer placed in the excitation path and the
emission intensity is collected. As anisotropy values are usually proportional to the size of
the fluorescent molecule, anisotropy represent a convenient approach to characterized
binding of small fluorescent molecules to proteins. By measuring anisotropy as a function
of an increasing concentration of the protein, the binding isotherm for fluorophore
association to the protein can be constructed and the equilibrium association or dissociation
constants can be determined by analyzing the experimental data using an appropriate
model.
Here we used the anisotropy approach to measure the dissociation constant for binding of
fluorescent labeled peptides that mimic DREAM binding sites in the T1 domain of
potassium voltage channels, so called site 1 and site 2. The site 1 corresponds to the
residues 2 to 22 of the T1 domain (FITC-AAGVAAWLPFARAAAIGWMPV)) and the
site 2 corresponds to the residues 70 to 90 of the T1 domain (FITCLLGSTEKEFFFNEDTKEYFFD). The peptides were labeled by a fluorescent probe
fluorescein isothiocyanate (FITC) (Scheme 2.1) covalently attached the peptide Nterminal.
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Fig. 2.3: Structure of FITC

Peptides were solubilized in 20 mM Tris buffer pH 7.8 and anisotropy was measured using
390 nm excitation light. The emission was collected through a long pass 500 nm filter
placed in the emission light pathway. Subsequently small aliquots of DREAM WT or
DREAM-NCS1 protein were added and anisotropy values were recorded. Each value of
anisotropy corresponds to an average value determined for 10 measurements. The values
of the anisotropy change were plotted as a function of protein concentration and the
titration curves were analyzed using quadratic equation (Eq. 5) and assuming a single
binding site for each peptide.

A =

(Kd + [Pt ] + [Lt ])-√(Kd + [Pt ] + [Lt ])2 - 4[Pt ][Lt ]
2𝑐

(5)

where A is the change in anisotropy, Kd is the equilibrium dissociation constant, Pt is the
total concentration of protein in the sample, Lt is the total ligand concentration of 0.5 µM,
and c is the proportionality constant.
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2.7 Circular Dichroism
Circular dichroism (CD) is a widely used technique to study protein secondary structure as
well as protein stability (Greenfield, 2007). In CD measurements, difference in the
absorbance of the right and left circularly polarized light in the far ultraviolet (UV) and
near UV spectrum is determined as chiral chromophore have a different extinction
coefficient for the left and right circularly polarized light. (Greenfield, 2007). The CD
spectra of protein in the far UV (190 nm to 250 nm) provides information of the secondary
structure of proteins major secondary structure elements, -helices, -sheets and random
coil, have a distinct CD spectrum as shown in Fig. 2.3.

Fig. 2.4: Typical CD spectra, showing the three major secondary structures of proteins,
α-helix, β-sheet and random coil with distinctive peak at specific wavelengths. Adapted
from Wei et al. (Wei, Thyparambil, & Latour, 2014)

For instance, α helical structures show a strong positive peak at 192 nm and two negative
peaks at 208 and 222 nm. In the case of β sheets, a negative peak at 218 nm and a positive
peak at 196 nm are observed whereas random coils show only a very week CD signal
(Greenfield, 2007). The monitoring of CD spectra in the near UV region are less common,
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however these data can provide information about structural changes in the environment
of aromatic residues Phe, Tyr and Trp.
The samples for CD measurement contained 20 µM protein in 20 mM Tris buffer pH 7.4
placed in a 0.1 mm x1 cm quartz cuvette. The apo, Mg2+, Ca2+ and Mg2+Ca2+ bound
DREAM was prepared by adding 5 mM EDTA,5 mM EGTA, 1 mM MgCl2 and/or 1 mM
CaCl2 to the protein samples. The data were collected from 190 to 260 nm using a J-810
Jasco CD spectrometer.

2.8 Isothermal Calorimetry

Isothermal calorimetry is a widely used analytical technique, which provides
thermodynamic parameters such as Keq, G, H and S using Eq (6) and (7)

𝐺 = −𝑅𝑇𝑙𝑛𝐾

(6)

𝐺 = H − TS

(7)

It determines the heat in a reaction process proportional to the molar enthalpy change
associated with the process and the amount of complex formed.
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Fig. 2.5: ITC instrumentation. Adapted from (Martinez et al., 2013)
The ITC experiments were performed employing a VP-ITC MicroCalorimeter (MicroCal
LLC, Northampton MA). The ITC instrument contains an adiabatic jacket with a reference
and a sample cell, where the titration occurs. The sensor measures the amount of heat
needed to keep the sample and reference cell temperature constant with every addition of
ligand, providing a heat signal as a function of time. The heat signal is integrated and
plotted as a function of molar ratios of the ligand and protein. The ITC data are then
analyzed using fitting models in Origin 7 software to calculate thermodynamic parameters
including number of binding sites (n), equilibrium association constant (Ka), reaction
enthanlpy change (ΔH) and reaction entropy change (ΔS) (MicroCal, LLC, Northampton,
USA). In the experiments presented in Chapter 3, the experimental data were fitted to one
sequential binding site model.
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3. INTERACTIONS OF DREAM WITH Zn2+ ION.
3.1 Introduction
Zinc is a key element in neuronal growth and activity and it is necessary for the normal
development and functioning of the brain (Plum, Rink, & Haase, 2010; Vallee & Falchuk,
1993). It has been found to interact with more than 50 different types of protein that require
Zn2+ to function (Vallee & Falchuk, 1993). It can be found intracellularly in concentrations
around the 100 pM and the free Zn2+ varies in nm-pM range (Plum et al., 2010). The
regulation of the physiological concentration of Zn2+ is crucial for the normal functioning
of the organism (Plum et al., 2010).
Zinc deficiency produces growth retardation and immune system dysfunctions (Plum et
al., 2010). Furthermore, neurologically there are several effects such as decreased nerve
conduction, neuropsychiatric disorders and mental lethargy (Plum et al., 2010).Whereas a
Zn2+ excess also affects the body by altering the lymphocyte function, producing
gastrointestinal issues and copper deficiency (Plum et al., 2010). In the brain, Zn2+ excess
causes lethargy and focal neuronal deficits (Plum et al., 2010). Recently, Permyakov et al.
have shown that Zn2+ binds to the member of neuronal calcium sensor family, recoverin
with a Kd of 7.0 µM (Permyakov, S. E. et al., 2003). Therefore, considering the role of Zn2+
in neuropathology and the high homology between recoverin and DREAM, as shown in
Figure 3.1, I suggest that DREAM may serve as a molecular target for Zn2+. To test Zn2+
interactions with DREAM I characterized DREAM emission properties in the presence of
DREAM as well as circular dichroism and isothermal titration calorimetry studies.
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Fig. 3.1: Sequence similarity among recoverin (PDB entry 1JSA) and DREAM (PDB entry
2JUL), identical residues in green, similar residues in pink, sequence mismatch in blue and
insertion/deletion in brown. Obtained from RCSB PDB Protein Comparison Tool. SmithWaterman sequence alignment (Smith & Waterman, 1981)

3.2 Steady state fluorescence emission
The Trp intrinsic fluorescence emission for the DREAM WT exhibits specific transitions
upon divalent metals addition along with a typical λmax at 330 nm. For DREAM WT, the
intensity decreases upon Ca2+ and Ca2+Mg2+ addition, whereas for addition of Mg2+ no
transition is observed with respect to the apo form. Emission spectra for Trp 169 were
detected upon Zn2+ addition to DREAM in the presence and absence of divalent metals, to
monitor Zn2+ binding to DREAM and its impact on Trp 169 surrounding. For the apo, Ca2+
, Mg2+ and Ca2+Mg2+ bound forms the Zn2+ addition resulted in an increase in the emission
at 330 nm, suggesting Zn2+

binds to the protein and triggers changes in the Trp

environment.
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Fig. 3.2: Steady-state fluorescence emission of Trp for DREAM-WT upon 500 µM Zn2+
addition in the presence and absence of Ca2+ and/or Mg2+.
Furthermore, titration curves for Zn2+ binding to DREAM WT were obtained by adding
increasing concentration of Zn2+ to DREAM samples and the Trp emission intensity was
monitored in the presence and absence of Ca2+ shown in Fig.ure 3.3.
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Fig. 3.3: Trp fluorescence emission for the Zn2+ association to Ca2+ (right) and apo (left)
DREAM WT
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The equilibrium dissociation constants were determined and are shown in Table 3.1.
Dissociation constant for Zn2+ binding to the apo form of the protein is around 3 times
lower than the one for the Ca2+bound form , suggesting a stronger affinity of Zn2+ for
DREAM WT in the absence of Ca2+.

Apo DREAMWT

Kd (μM)
4.30.9

Ca2+ DREAMWT

14.03.1

Table 3.1: Dissociation constant for Zn2+ association to
DREAMWT in the presence and absence of Ca2+.

3.3 CD measurements
The secondary structure changes upon Zn2+ addition to the protein were measured using
circular dichroism for DREAM WT in the absence and presence of divalent metals shown
in Fig.ure 3.6
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Fig. 3.4: Secondary structure characterization of DREAM WT upon Zn 2+ addition in the
absence and presence of Ca2+, Mg2+ and Ca2+Mg2+.
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A decrease in CD signal was observe upon Zn2+ in all the cases , for the apo form a more
pronounced decrease in the CD signal was observed when compared to the Ca2+ , Mg2+
and Ca2+Mg2+ forms. Suggesting the Zn2+ binding to apo DREAM leads to the significant
increase in the protein secondary structure and possibly to the stabilization of the protein
structure. In decrease in the CD signal in the presence of Mg2+ and Ca2+ was less
pronounced, suggesting that the presence of Mg2+ and Ca2+ in the EF-hands modulates
Zn2+ impact on the protein secondary structure.

3.4 Impact of Zn2+ on DREAM interactions with hydrophobic probe, 1,8-ANS
The fluorescence emission of 1,8 ANS-DREAM complex in the presence and/or absence
of Ca2+, Mg2+ was monitored in order to determine impact of Zn2+ binding on the
accessibility of hydrophobic surfaces on the protein surface . The emission spectra for
DREAM in the absence/ presence of divalent ions are shown in Figure 3.4 .
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Fig. 3.5: Emission spectra of 1,8 ANS-DREAM WT complex in the presence and/or
absence of Ca2+, Mg2+ and Zn2+.
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For the 1,8 ANS-DREAMWT apo, Ca2+ , and Ca2+Mg2+ bound forms the Zn2+ addition
resulted in an increase in the 1,8-ANS emission intensity. The largest increase in intensity
was observed for the apo form and interestingly for the Mg2+ bound form of DREAM W,
the Zn2+ triggered changes in the emission intensity were negligible that is consistent with
the CD data. Furthermore, the equilibrium dissociation constant for 1,8 ANS binding to
DREAM in the presence of Zn2+ was determined by monitoring the increase in the
emission intensity upon Zn2+ titration into 1,8 ANS-DREAMWT complex in the presence
and absence of Ca2+ . The corresponding titration curves areas shown in Figure 3.6.
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Fig. 3.6: Zn2+ association to Ca2+ and Apo DREAM WT in the presence of 1,8 ANS

The Kd values were obtained by fitting the data using the Hill equation (Eq. 4.1) and are
shown in Table 3.2. Slightly smaller Kd value was determined for apoDREAM compared
to the Ca2+ bound protein, in agreement with the Trp emission data.

Kd (μM)
Apo DREAMWT
Ca2+DREAMWT

6.9  0.6
10.76 1.46

Table 3.2: Dissociation constant for 1,8 ANS - DREAMWT
association with Zn2+ in the presence and absence of Ca2+.
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In addition, the impact of Zn2+ on the fluorescence lifetimes of 1,8-ANS: DREAM complex
in the presence and absence of Ca2+ was probed using frequency modulation approach and
the date are presented in Fig. 3.7 . The lifetime values were obtained from a fit of
experimental data using a three exponential decay model and the fitting parameters are
summarized in Table 3.3. The lifetime for unbound 1,8-ANS was fixed to 0.27 ns
(Gonzalez & Miksovska, 2014). Upon Zn2+ addition, τ1 decreased from 5.9 ns to
approximately 3.0 ns for both apo and Ca2+bound protein, while Zn2+ association does not
impact the longer lifetime, τ2. These results suggest that the 1,8-ANS-binding site with the
shorter lifetime, τ1, is more sensitive to the structural changes

triggered Zn2+ binding

whereas the emission properties of 1,8-ANS bound to the second site are only slightly
affected by the Zn2+ association.

Fig. 3.7: Frequency domain intensity decay for Zn2+ addition to Ca2+ bound 1,8-ANSDREAMWT (left) and 1,8 ANS- apo DREAM-WT (right). The solid lines correspond to
the fit of the experimental data using a sum of three exponential decay model.
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Table 3.3: 1,8 ANS lifetime for apo and Ca-DREAM WT in the presence of
Zn2+fitted to three exponential decays with a fixed lifetime for 1,8 ANS of 0.27
ns. The lifetime values for 1,8 ANS bound to DREAM in the absence of Zn2+
were previously determined by Gonzalez (Gonzalez & Miksovska, 2014)
τ 1 (ns)

τ 2 (ns)

α1

α2

χ2

5.9± 0.1

16.2 ± 0.7

0.13

0.23

1.16

5.9± 0.2

17.6 ± 0.5

0.18

0.42

1.13

1,8 ANS-Apo DREAMWT+ Zn

2.89 ± 0.2

14.4 ± 0.2

0.07

0.06

9.45

1,8 ANS-Ca2+DREAMWT+Zn2+

3.13 ± 0.09

14.1 ± 0.1

0.05

0.05

4.05

1,8 ANS Apo DREAM WT
1,8 ANS Ca2+DREAM WT
2+

3.5 ITC studies
Isothermal calorimetry studies were performed to determine the dissociation constant and
thermodynamic parameters for Zn2+ binding to apo DREAM. The binding isotherm is
shown in Fig. 3.8. The data were analyzed using one binding site model. The Zn2+ binding
to the protein is exothermic, with the reaction enthalpy change of -5.1 kcal mol-1 (Table
3.4) and the equilibrium dissociation constant was determined to be 3±1 µM. This value of
3±1 µM is similar to the Kd value obtained from monitoring changes in Trp 169 emission
in apo DREAM, Kd = 4.3±0.9 µM and 1,8-ANS:apoDREAM emission, Kd = 6.9  0.6
µM.
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Fig. 3.8: ITC Isotherms for Zn2+ association to DREAM in the absence of Ca2+, the upper
panel refers to thermal power as function of time, and the lower panel represent the
integrated reaction heat H in kcal/mol.

Zn2+apo DREAM WT

KD (µM)

H (kcal/mol)

TS (kcal/mol)

2.6± 1.0

- 5.1

23.7

Table 3.4: Equilibrium Dissociation constant of Zn2+ binding to DREAM in the
absence of Ca2+Using one model sequential binding fitting.
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3.6 Discussion
The fluorescence and CD results presented in the chapter for Zn2+ interactions with
DREAM suggest that Zn2+ binds to DREAM with relatively high affinity, Kd ~ 5 µM. The
increase in the emission spectra for the Trp residue indicates that Zn2+ association impact
the tertiary structure of the protein. The dissociation constant obtained for Zn2+ binding to
apo and Ca2+ DREAM of 5 µM and 14 µM, respectively, is similar to the value reported
for recoverin, Kd = 7 µM (Permyakov, S. E. et al., 2003). The dissociation constant
obtained for Zn2+ binding to DREAM in the absence of Ca2+ through fluoresce emission
of 4µM,

is very close to the Kd = 3 µM obtained through isothermal calorimetry

measurements, suggesting a higher affinity of Zn

2+

to DREAM in the absence of the

physiological ligand. In addition, the decrease in the CD signal suggest a stabilizing effect
on the protein structure similar to the one occurring upon Ca2+ addition. Furthermore, the
addition of Zn2+ to 1,8 ANS –DREAM complex resulted in an increase in the fluorescence
intensity, suggesting a higher exposure of the hydrophobic surfaces due to the Zn2+ binding.
The emission data is in agreement with the 1,8 ANS lifetime values, which demonstrate a
lower τ1 upon Zn2+ addition, suggesting that 1,8 ANS binding site 1 is more sensitive to
the Zn2+ conformational changes. Overall, the data obtained confirm that Zn2+ binds to
DREAM in apo and Ca2+ bound form, and association of Zn+ to the protein triggers
changes in protein. Maret et al studied zinc-protein interactions and reported that Zn2+ is
usually coordinated in proteins by four ligands with the side chain of Cys, His, Glu, or Asp
being the most common ligands (Maret & Li, 2009). The inspection of the monomeric
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structure of the calcium bound protein (PDB entry 2JUL, Lusin et al, 2008) did not reveal
a possible binding site on the DREAM monomer. However, it is likely that the Zn2+
association to the protein requires the presence of the apo protein tetramer or Ca2+ bound
protein dimer and thus additional studies are necessary to identify residues that participate
in Zn2+ coordination.
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4. MOLECULAR MECHANISM OF DREAM DIMERIZATION
4.1 Introduction
Unlike traditional EF hand sensors, such as calmodulin and troponin C that remind in the
monomeric form in the absence and presence of Ca2+, Ca2+ association to other CBPs
triggeres a structural transition that facilittes protein oligomeriztion. For example, proteins
belonging to S100 calcium binding protein subfamily are known to undergo dimerization
upon Ca2+ binding to the EF hands. Some members of the neuronal calcium sensor family
also undergo Ca2+ triggered dimerization such as recoverin, GCAP 1-5 and VILIP1(Ames, 2018) (James 2018[JM3]). The available structures of dimeric form of individual
proteins suggest, that each protein adopt a unique dimeric structure, as shown in Fig.ure
4.1, likely due to a distinc physiological role of each proteins (James, 2018). For example,
the dimeric structure of Ca2+ bound VILIP-1 shows that the binding interface is formed
through contacts beween -helices located in EF-hand 4 of the C- terminal domain (Li,
Pan, Braunewell, & Ames, 2011) (Li et al., 2011[JM4]), whereas in recoverin, the exiting
-helix from the EF-hand 4 interacts with hydrophobic residues in a cavity located between
EF-hand 1 and EF-hand 2 (Myers et al., 2013) (Myers et al., 2013[JM5])
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Fig. 4.1: The structure of the dimeric form of recovering (left) and VILIP-1 (right) in Ca2+
bound form. Individual monomers are colored in yellow and blue and side chains of
residues in the binding interfaces are shown in red. Adapted from Ames 2018 (Ames, 2018)

Based on the NMR structure of Ca2+ bound DREAM monomer, Lusin et al. suggested that
DREAM forms a dimeric structure with the head to tail orientation of the C- and Nterminal domain (Lusin et al, 2018). The dimeric form was proposed to be stabilized by
hydrohobic interactions between Leu residues in the N- terminal domain (Leu 155 and
Leu 159) of one monomer and Leu 251 in the C- terminal domain of the second monomer.
Albeit replacement of Leu residues by Ala did not abolished the formation of the dimers,
but the equilibrium constant for the protein dimerization decreased (Lusin et al, 2018). The
DREAM dimeric structure is destabilized at an increased concentration on sodium
chloride as observed in the homo Förster resonance energy transfer measurement ,
suggesting that ionic interactions also contribute to the formation of DREAM dimeric form
(unpublished results from Dr. Miksovska group).
In order to better understand the mechanism of Ca2+ triggered protein dimerization and the
mechanism of signal transduction in DREAM, we prepared a DREAM construct with the
aim to abolish protein dimerization. Based on the previously published model structure of
DREAM (Lusin et al, 2018), a protein docking and molecular dynamic simulation of the
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DREAM dimer structure, Fig. 4.3, (Miksovska laboratory, unpublished results) and the fact
that other member of neuronal calcium sensor family, NCS1, does not form a dimer[JM6]
(Pandalaneni et al., 2015), I proposed to construct a chimeric variant of a protein with Leu
residues in position 155 and 158 replaced by residues Thr and Leu, that are found in NCS1 respectively. In addition, since the simulated structure of DREAM dimer shows an
interactions between Arg residues(Arg 200 and Arg 208) in the long loop conecting EFhand 3 and EF-hand 4, the residues in the loop were replaced by residues found in the loop
in NCS-1. I label this chimeric form of the protein DREAM-NCS-1. The alignment of the
sequence of DREAM-NCS-1 and the sequence of DREAM WT in Fig. 4.2. The properties
of DREAM-NCS-1 variant were characterized using fluorescence and CD spectroscopy
and the interactions with the peptides mimicking the DREAM binding sites in T1 domain
of potassium voltage channels were determined.

MELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDAD
MELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDAD
GNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERF
GNGAIHFEDFVVGLSITSRGTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGNTVELPEEEDAPLEHVERF
FQKMDRNQDGVVTIDEFLETCQKDENIMNSMQLFENVIYLEHHHHHH
FQKMDRNQDGVVTIDEFLETCQKDENIMNSMQLFENVIYLEHHHHHH
Fig. 4.2: Sequence of mouse DREAM WT (red) with a start methionine residue (green)
and a C-terminus His-tag (blue) connected by tripeptide linker (green). The DREAMNCS (black) has identical sequence to the DREAM WT except residues L158, Leu159
replaced by Thr and Ser and the loop between EF-hand 3 and 4 (shown in yellow )
replaced by the amino acid sequence found in human NCS-1 (shown in bold red).
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Fig. 4.3: Model structure of DREAM dimer based on the NMR structure of DREAM
monomer (PDB entry 2JUL). Left panel shows hydrophobic interactions between Leu 155,
159 and 251 and right panel show a salt bridge between Arg 200, Arg 207 (in blue) and
Glu 103 (in red).

4.2 Steady state fluorescence emission
Trp 169 fluorescence emission spectrum of DREAM WT presents a characteristic λmax at
330 nm, Fig. 4.4. The emission intensity decreases upon Ca2+ and Ca2+Mg2+ addition to the
apo protein sample, whereas upon addition of Mg2+, no changes are observed with respect
to apoDREAM WT. Interestingly, when analyzing the Trp steady state emission of the
DREAM-NCS1 variant, the spectrum of the apoform exhibits a red shift with respect to
DREAM WT, with a λmax at 337 nm. Furthermore, , the emission intensity increases upon
Ca2+ and Ca2+Mg2+ addition , while Mg2+ binding to the apoprotein does not modulate the
emission intensity as shown in Fig. 4.4. The increase in the Trp 169 emission observed for
Ca2+DREAM-NCS-1 is distinct from the DREAM WT, which exhibits an opposite trend,
decrease in the emission internist in the presence of Ca2+.
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Fig. 4.4: Steady-state fluorescence emission of Trp for DREAM-WT (left) and
DREAM-NCS1 (right) in the presence and absence of Ca2+ and/or Mg2+.

4.3 CD spectra
The changes in the secondary structure were monitored by performing CD measurements
for both DREAM WT and DREAM-NCS 1 in the presence and absence of divalent metals.
For DREAM WT and DREAM-NCS 1 a decrease in the CD signal is observed upon
addition of divalent metals, similar to other NCS where Ca2+ binding leads to the increase
in the α-helical contain of the protein Azam at al, 2019 (Azam & Miksovska, 2019)[JM7].
These results together with the emission data indicate that Ca2+ binds to the chimeric
version of the protein. In addition, the substitution of Leu residues and the modification of
the loop connecting the EF-hand 3 and EF-hand 4 does not destabilizes the protein
secondary structure and protein fold.
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Fig. 4.5: Circular dichroism spectra for DREAM WT (left) , and DREAM-NCS1 (right)
in the presence and absence of Ca2+ and/or Mg2+.
4.4 Ca2+ triggered exposure of hydrophobic cavities
1,8-ANS is a small hydrophobic molecule that is very weakly fluorescent in aqueous
solution but its fluorescent quantum yield increases significantly upon binding to
hydrophobic cavities on a protein surface (Gasymov & Glasgow, 2007) . Two binding
sites with a high affinity for 1,8-ANS were identified for DREAM WT in the C-terminal
domain and the analysis of the emission data indicates that 1,8-ANS binds to DREAM WT
in Ca2+ dependent manner. (Gonzalez & Miksovska, 2014) The emission spectra of 1,8ANS bound to DREAM-NCS 1 in the apo form and in the presence of Ca2+ and/or Mg2+
are shown in Fig. 4.6. The results show a transition towards increase emission intensity of
1,8-ANS upon binding of Ca2+as well as in the presence of Mg2+. The λmax for apo DREAM
is around the 471 nm, while the metal bound protein exhibits a red to a λmax of 491 nm
shift with respect to apo DREAM.
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Fig. 4.6: 1,8 ANS-DREAM-NCS 1 emission spectra upon Ca2+ , Mg2+ and Ca2+Mg2+
addition.
In order to gain more information about 1,8-ANS interactions with DREAM-NCS-1, the
equilibrium dissociation constant for 1,8- ANS binding to DREAM were determined by
titrating apo DREAM-NCS 1 and Ca2+ DREAM-NCS-1 with 1,8-ANS. The titration curves
were constructed by plotting the increase in the emission intensity for 1,8-ANS additions
to DREAM-NCS-1 as shown in Fig. 4.7.
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Fig. 4.7: Titration curves for 1,8-ANS binding to apoDREAM-NCS 1 (left) and
Ca2+DREAM-NCS 1 (right).
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Affinity constants for 1,8-ANS binding to apoDREAM-NCS-1 and Ca2+ bound DREAM
were determined by analyzing the titration curves using Hill equation (Eq. 4.1):
[1,8−𝐴𝑁𝑆]𝑛

𝐹 = 𝐵𝑚𝑎𝑥 [1,8−𝐴𝑁𝑆]𝑛+𝐾

(4.1)

𝐷

where F is the observed emission intensity, n is the Hill coefficient, KD is the equilibrium
dissociation constant and Bmax is the proportionality constant. The fitting parameters are
summarized in Table 4.1 together with the data obtained for 1,8-ANS binding to DREAM
WT. Interestingly, the affinity of 1,8-ANS for DREAM-NCS-1 increased in the apo form
and Ca2+ bound form, compared to the DREAM WT, pointing towards increased
accessibility of the hydrophobic sites in the chimeric variant.

Table 4.1: Dissociation constants and Hill coefficients for 1,8 ANS binding to
DREAM-NCS1 and DREAM WT.
KD (μM)
n
Apo DREAM-WT

195 ±20

1.1±0.1

Apo DREAM-NCS 1

32±2

1.9±0.1

Ca2+ DREAM-WT

62 ± 4

1.1±0.1

Ca2+ DREAM-NCS 1

22 ±4

1.3±0.2
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4.5 Fluorescence lifetime of Trp169

Lifetime decay parameters for the Trp 169 residue were determined using a frequency
domain approach and the plot of the phase shift and modulation ratio as a function of

Fig. 4.8: Frequency domain Trp intensity decay for apo DREAM-NCS 1(left) and Ca2+
bound DREAM-NCs 1 (right). The solid lines correspond to the fit of the experimental
data using a sum of three exponential decay model
modulation frequency is shown in Fig. 4.8. The curves were analyzed using sum of three
exponential decay model and the decay parameters are summarized in Table 4.2 for
Table 4.2: : Emission decay parameters for DREAM WT and DREAM-NCS 1 in the
presence and absence of Ca2+ and Mg2+.
Average
lifetime
(ns)
Apo DREAM WT

3.69

Ca2+DREAM WT

4.07

Mg 2+DREAMWT

4.95

Apo DREAMNCS 1

4.42

Ca2+DREAMNCS 1

4.81

Mg2+DREAMNCS1

3.87

τ 1 (ns)

τ 2 (ns)

0.39±
0.03
0.47±
0.02
0.13 ±
0.01
0.42±
0.05
0.58±
0.03
0.48±0
.04

2.28 ±
0.1
2.57 ±
0.01
1.22 ±
0.08
2.15±
0.2
2.78±
0.2
2.14±
0.3
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τ3(ns)
6.6 ± 0.3
7.3 ± 0.3
10.1 ±
0.3
6.36±
0.3
8.11±
0.7
5.87±
0.3

α1

α2

α3

0.2
9
0.2
9
1.8
5
0.2
9
0.2
7
0.3
4

0.2
9
0.1
9
0.1
5
0.1
4
0.1
6
0.1
4

0.2
9
0.0
5
0.0
4
0.0
9
0.0
5
0.0
9

χ2
4.38
2.93
3.105
0.91
0.75
0.98

DREAM-NCS-1 and DREAM-WT in the presence and absence of divalent metal.
To provide additional information about the changes in the hydrophobic cavities on the
protein surface, I have determined the lifetime of 1,8-ANS bound to DREAM-NCS 1 in
the presence and the absence of Ca2+ using frequency domain approach. The data were
Table 4.3: Decay parameters for 1,8 ANS –DREAM WT and 1,8 ANS- DREAM-NCS
1 complex in the presence and absence of Ca2+.The data were analyzed using a three
exponential decay model. The data for DREAM WT are from Ref. Gonzalez and
Miksovska, 2014.
τ 1 (ns)

τ 2 (ns)

α1

α2

χ2

1,8 ANS Apo DREAM WT

5.9± 0.1

16.2 ± 0.7

0.13

0.23

1.16

1,8 ANS Ca2+DREAM WT

5.9± 0.2

17.6 ± 0.5

0.18

0.42

1.13

1,8 ANS Apo DREAM-NCS1

4.72± 0.2

16.5± 0.3

0.05

0.04

2.31

1,8 ANS Ca2+DREAM-NCS 1

4.40± 0.2

16.4± 0.3

0.04

0.04

1.98

analyzed using a sum of three discreet exponential decays and the decay parameters are
provided in Table 4.3.. The lifetime of 1,8-ANS unbound to protein was fixed to 0.27
(Gonzalez & Miksovska, 2014). The decay parameters for 1,8 ANS- DREAM WT were
previously determined (Gonzalez & Miksovska, 2014) and are listed for the comparison.
Interestingly, the lifetimes τ

1

and τ

2

are similar for both the WT and the mutant,

suggesting that the binding sites for 1,8-ANS are identical in DREAM WT and DREAMNCS-1.
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Site 1 and site 2 interactions with DREAM-NCS 1
Previous data shown that binding of peptides mimicking the DREAM binding site 1 and
site 2 in the T1 domain of Kv channel DREAM is regulated by Ca2+ and the affinity of
DREAM for site 1 and site 2 increases approximately 25 and 50 times, respectively
(Gonzalez and Miksovska, 2014).
Site 1 and site 2 interactions with DREAM-NCS were monitored by measuring the change
in anisotropy upon DREAM-NCS 1 addition to peptides with a FITC fluorescent probe
covalently attached to the N- terminus in the presence and absence of Ca2+. Increase in the

Fig. 4.9: Cartoon presentation of the interactions between FITC labeled site 1 (shown in
purple) and DREAM (shown in light blue). Ca2+ ions are shown in yellow.

size of the FITC-labeled peptide upon complexation with DREAM protein (see Scheme
4.1) results in the increase in the anisotropy. Thus monitoring an increase in anisotropy as
a function of the increased concentration of DREAM provides a convenient way determine
the affinity of DREAM for individual peptides.
The titration curves for site 2 and site 1 binding to DREAM-NCS-1 in the absence and
presence of Ca2+ are shown in Fig. 4.10 and Fig. 4.11, respectively. For both sites, the
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anisotropy increases upon protein addition, suggesting that the chimeric protein binds both
peptide. Analysis of titration curves using a quadratic equation as described in Material
and Method section, provided equilibrium dissociation constants that are listed in Table
4.4.
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Fig. 4.10: Increase in anisotropy for Site 2 titration with DREAM –NCS 1 in the
presence (left) and absence (right) of Ca2+. The solid line corresponds to the fit of the
experimental data using quadratic equation (Eq. 2.5)
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Fig. 4.11: Increase in anisotropy for Site 1 titration with DREAM –NCS 1 in the
presence (left) and absence (right) of Ca2+. The solid line corresponds to the fit of the
experimental data using quadratic equation (Eq. 2.5)
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Table 4.4: Dissociation constant for DREAM-NCS 1 interactions
with Site 1 and Site 2 peptides , in the presence and absence of Ca2+.

Apo DREAM-NCS 1- Site 1

KD (μM)
13.7 ±0.8

Apo DREAM-NCS 1 – Site 2

3.9±0.60

2+

Ca DREAM-NCS 1 Site 1

7.9 ± 0.8

Ca2+ DREAM-NCS 1 Site 2

9.0 ± 1.9

The equilibrium dissociation constants determined for site 1 and site 2 binding to DREAMNCS-1 chimeric variant show an increased affinity compared to DREAM WT data and
more importantly, the affinity for site 1 and site 2 is only weakly influenced by the presence
of Ca2+ as the affinity for site 1 increases only two times in the presence of Ca2+ whereas
affinity of Ca2+ bound DREAM-NCS-1 is approximately 2.5 weaker in the presence of
Ca2+ compared to the metal free protein.
4.6 Discussion
Here we present the characterization of structural and functional properties of the chimeric
DREAM-NCS-1. The Trp 169 emission spectra indicate that the replacement of Leu
residues by Ser and Thr as well as modification of the loop between EF-hand 3 and EFhand 4 strongly impact the Trp 169 surrounding as the emission spectra are red shifted,
likely due to the more polar environment of the intrinsic probe. The different transition
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upon Ca2+ binding to apoDREAM-NCS-1 compared to DREAM WT was observed, i.e.
increase in the emission intensity, indicating distinct changes in the tertiary structure of the
chimeric protein in the presence of Ca2+. Interestingly, similar increase in the emission
intensity upon Ca2+ association was observed previously for Ca2+ binding to NCS-1
(Aravind et al., 2008) (Aravid et al, 2008)[JM8],suggesting that photo-physical properties
of Trp 169 in the chimeric protein resemble to those observed for NCS-1, at least in the
presence of Ca2+. However, the Trp 169 lifetime data determined for the chimeric
DREAM-NCS-1 f or DREAM-WT suggest similar dynamic properties of Trp 169 and its
surrounding in both proteins. The CD data clearly demonstrate that despite the red shift in
the Trp emission spectrum, the chimeric protein has similar secondary structure DREAM
WT and thus the absence of Leu 158 and Leu 159 residues as well as substitution of
residues in the loop connecting EF-hand 3 and EF-hand 4 did not perturbed the proteins
structure. The emission spectra of 1,8-ANS probe bound to apo DREAM-NCS-1 and Ca2+
bound DREAM-NCS-1 ( λmax = 471 nm and 491 nm, respectively) are red shifted with
respect to the maxima of 1,8-ANS bound apoDREAM WT and 1,8-ANS bound
Ca2+DREAM (λmax = 461 for both adducts, Gonzalez and Miksovska, 2014 ), suggesting
that hydrophobic cavities are somewhat more polar in the chimeric protein. In addition, the
affinity of the dimeric protein for 1,8-ANS increases 6 times and 3 times in the absence
and presence of Ca2+, respectively. We associate the increase in the affinity for a,8-ANS
with the absence of the tetrameric and dimeric state in the apo and Ca2+ bound form of
DREAM-NCS-1 due to the increased accessibility of the hydrophobic cavities.
The chimeric version of the protein interacts more closely with the peptides mimicking the
site 1 and site 2 binding sites in the Kv channel T1 domain. Analogously with the increased
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affinity for 1,8-ANS, these data indicates increased accessibility of the site1 and site2
binding sites on the protein surface due to the lack of the apoDREAM-NCS-1 tetramer and
Ca2+DREAM-NCS-1 dimer. Interestingly, Ca2+ regulated increase affinity of DREAM WT
for site 1 and site 2 is not observed in this construct, suggesting, that the presence of the
dimeric form is necessary for Ca2+ regulation of DREAM affinity for site 1 and site 2
binding sites.
Although these data points towards a distinct oligomerization form of chimeric DREAMNCS-1 protein, additional experiments, that directly monitor the changes in protein
oligomerization, such as dynamic light scattering, are necessary to confirm the above
results. Also, molecular dynamic studies will provide insight into the distinct structural
properties of DREAM-NCS-1.
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